These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Buspirone in the treatment of tardive dyskinesia.
    Author: Ross CA.
    Journal: Med Hypotheses; 1987 Mar; 22(3):321-8. PubMed ID: 2884555.
    Abstract:
    Buspirone is a novel anxiolytic chemically unrelated to the benzodiazepines. In clinical trials it has been shown to be as effective as diazepam, with fewer side effects. Buspirone is primarily active in dopaminergic pathways. It has the properties of both a dopamine agonist and antagonist. In this paper a model for treatment of tardive dyskinesia with buspirone is developed, based on dopamine autoreceptor blockade. A clinical trial of buspirone in the treatment of movement disorders is warranted.
    [Abstract] [Full Text] [Related] [New Search]